Online citations, reference lists, and bibliographies.
← Back to Search

Proton Therapy For Malignant Pleural Mesothelioma After Extrapleural Pleuropneumonectomy.

J. Krayenbuehl, M. Hartmann, A. Lomax, S. Kloeck, E. Hug, I. Ciernik
Published 2010 · Medicine

Cite This
Download PDF
Analyze on Scholarcy
Share
PURPOSE To perform comparative planning for intensity-modulated radiotherapy (IMRT) and proton therapy (PT) for malignant pleural mesothelioma after radical surgery. METHODS AND MATERIALS Eight patients treated with IMRT after extrapleural pleuropneumonectomy (EPP) were replanned for PT, comparing dose homogeneity, target volume coverage, and mean and maximal dose to organs at risk. Feasibility of PT was evaluated regarding the dose distribution with respect to air cavities after EPP. RESULTS Dose coverage and dose homogeneity of the planning target volume (PTV) were significantly better for PT than for IMRT regarding the volume covered by >95% (V95) for the high-dose PTV. The mean dose to the contralateral kidney, ipsilateral kidney, contralateral lung, liver, and heart and spinal cord dose were significantly reduced with PT compared with IMRT. After EPP, air cavities were common (range, 0-850 cm(3)), decreasing from 0 to 18.5 cm(3)/day. In 2 patients, air cavity changes during RT decreased the generalized equivalent uniform dose (gEUD) in the case of using an a value of < - 10 to the PTV2 to <2 Gy in the presence of changing cavities for PT, and to 40 Gy for IMRT. Small changes were observed for gEUD of PTV1 because PTV1 was reached by the beams before air. CONCLUSION Both PT and IMRT achieved good target coverage and dose homogeneity. Proton therapy accomplished additional dose sparing of most organs at risk compared with IMRT. Proton therapy dose distributions were more susceptible to changing air cavities, emphasizing the need for adaptive RT and replanning.
This paper references
10.1016/J.IJROBP.2005.07.957
Repeat CT imaging and replanning during the course of IMRT for head-and-neck cancer.
E. Hansen (2006)
10.1038/sj.bjc.6690105
The European mesothelioma epidemic
J. Peto (1999)
10.1016/J.IJROBP.2007.03.011
Dose-dependent pulmonary toxicity after postoperative intensity-modulated radiotherapy for malignant pleural mesothelioma.
D. Rice (2007)
10.1016/J.IJROBP.2006.03.012
Fatal pneumonitis associated with intensity-modulated radiation therapy for mesothelioma.
A. Allen (2006)
10.1016/j.radonc.2007.12.010
Evaluating target coverage and normal tissue sparing in the adjuvant radiotherapy of malignant pleural mesothelioma: helical tomotherapy compared with step-and-shoot IMRT.
F. Sterzing (2008)
10.1118/1.598063
Reporting and analyzing dose distributions: a concept of equivalent uniform dose.
A. Niemierko (1997)
10.1016/S0167-8140(02)00308-0
Intensity modulation in radiotherapy: photons versus protons in the paranasal sinus.
A. Lomax (2003)
10.1016/j.ijrobp.2008.04.014
Underestimation of low-dose radiation in treatment planning of intensity-modulated radiotherapy.
Si Young Jang (2008)
10.1016/J.IJROBP.2005.08.002
Investigation of clinical and dosimetric factors associated with postoperative pulmonary complications in esophageal cancer patients treated with concurrent chemoradiotherapy followed by surgery.
S. Wang (2006)
10.1016/J.IJROBP.2004.09.030
Radical radiotherapy for cervix cancer: the effect of waiting time on outcome.
C. E (2005)
10.1634/THEONCOLOGIST.12-7-850
Multidisciplinary treatment of malignant pleural mesothelioma.
G. Ceresoli (2007)
10.1016/S0360-3016(02)04151-2
Intensity-modulated radiation therapy: a novel approach to the management of malignant pleural mesothelioma.
A. Ahamad (2003)
10.1016/J.IJROBP.2005.03.041
Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma.
V. Gupta (2005)
10.1016/J.IJROBP.2004.10.011
Low-dose megavoltage cone-beam CT for radiation therapy.
J. Pouliot (2005)
10.1016/J.IJROBP.2003.12.024
Quantification of volumetric and geometric changes occurring during fractionated radiotherapy for head-and-neck cancer using an integrated CT/linear accelerator system.
Jerry Barker (2004)
10.1016/S0003-4975(96)01228-3
Patterns of failure after trimodality therapy for malignant pleural mesothelioma.
E. Baldini (1997)
10.1088/0031-9155/53/13/R01
A review of dosimetry studies on external-beam radiation treatment with respect to second cancer induction.
X. Xu (2008)
10.1016/S0022-5223(99)70469-1
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: results in 183 patients.
D. Sugarbaker (1999)
10.1016/J.LUNGCAN.2005.08.001
Corrigendum to “Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the palliative treatment of malignant mesothelioma of the pleura: The Heidelberg experience” [Lung Cancer 49S1 (2005) S83–S86]
M. Muenter (2005)
10.1016/J.IJROBP.2007.07.2370
Combined photon and electron three-dimensional conformal versus intensity-modulated radiotherapy with integrated boost for adjuvant treatment of malignant pleural mesothelioma after pleuropneumonectomy.
J. Krayenbuehl (2007)
10.1016/S0360-3016(02)04150-0
Intensity-modulated radiotherapy following extrapleural pneumonectomy for the treatment of malignant mesothelioma: clinical implementation.
K. Forster (2003)
10.1016/J.IJROBP.2007.07.2345
Parotid gland dose in intensity-modulated radiotherapy for head and neck cancer: is what you plan what you get?
J. O'Daniel (2007)
10.1080/14774003.2005.11667666
Diffuse Pleural Mesothelioma and Asbestos Exposure in the North Western Cape Province
Tim J. Carter (2005)
10.1016/J.RADONC.2006.04.007
A novel radiation therapy technique for malignant pleural mesothelioma combining electrons with intensity-modulated photons.
M. Chan (2006)
10.1118/1.597522
The 200-MeV proton therapy project at the Paul Scherrer Institute: conceptual design and practical realization.
E. Pedroni (1995)
10.1200/JCO.2004.10.071
Neoadjuvant chemotherapy followed by extrapleural pneumonectomy in malignant pleural mesothelioma.
W. Weder (2004)
10.1016/J.LUNGCAN.2005.03.031
Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the palliative treatment of malignant mesothelioma of the pleura: the Heidelberg experience.
M. Muenter (2005)
10.1088/0031-9155/48/3/301
Intensity-modulated radiotherapy optimization with gEUD-guided dose-volume objectives.
Qiuwen Wu (2003)
10.1016/J.IJROBP.2007.06.075
Restricted field IMRT dramatically enhances IMRT planning for mesothelioma.
A. Allen (2007)
10.1016/J.IJROBP.2005.03.026
Correlation of dosimetric factors and radiation pneumonitis for non-small-cell lung cancer patients in a recently completed dose escalation study.
E. Yorke (2005)
10.1016/J.IJROBP.2007.08.026
Verification of in-treatment tumor position using kilovoltage cone-beam computed tomography: a preliminary study.
K. Nakagawa (2007)



This paper is referenced by
10.3978/j.issn.2225-319X.2012.10.07
Novel radiation therapy approaches in malignant pleural mesothelioma.
A. Rimner (2012)
10.1586/era.10.169
Malignant pleural mesothelioma: when is radiation therapy indicated?
Eric RE van Thiel (2011)
10.1002/acm2.12503
Impact of aeration change and beam arrangement on the robustness of proton plans
N. Shusharina (2019)
10.1016/j.cllc.2018.04.019
Utilization of Intensity‐Modulated Radiation Therapy for Malignant Pleural Mesothelioma in the United States
S. Shaaban (2018)
10.1634/theoncologist.2011-0019
The need for randomized trials in mesothelioma: let's walk the talk.
T. Treasure (2011)
10.1016/j.cllc.2018.08.019
Moderately Hypofractionated Helical IMRT, FDG–PET/CT‐guided, for Progressive Malignant Pleural Mesothelioma in Patients With Intact Lungs
A. Fodor (2019)
Scientific Report 2010
Centro Nacional de Investigaciones Cardiovasculares (2011)
10.21037/jxym.2018.07.02
Chest tumors: current trends of clinical practice
Patricia Tai (2018)
10.1093/jrr/rru102
Clinical experience of volumetric modulated arc therapy for malignant pleural mesothelioma after extrapleural pneumonectomy
T. Kimura (2015)
10.1016/j.prro.2014.11.005
Early experience with intensity modulated proton therapy for lung-intact mesothelioma: A case series.
H. Pan (2015)
or Incompletely Resected Osteosarcoma
I. Frank Ciernik (2011)
10.1007/978-3-319-28761-4_20
Modern Radiotherapy Techniques in Malignant Pleural Mesothelioma
G. Ozyigit (2016)
10.1016/J.IJROBP.2010.10.050
In Response to Dr. Russi and Colleagues
M. Scorsetti (2011)
10.1007/s00066-011-0038-3
Adjuvant intensity-modulated proton therapy in malignant pleural mesothelioma
S. Lorentini (2011)
10.1111/1754-9485.12312
Hemithoracic radiation therapy after extrapleural pneumonectomy for malignant pleural mesothelioma: Applicable to all and by all?
R. Haas (2015)
10.21037/tlcr.2018.04.07
Proton beam therapy for malignant pleural mesothelioma.
S. Badiyan (2018)
10.1007/s00066-017-1108-y
Does selective pleural irradiation of malignant pleural mesothelioma allow radiation dose escalation?
A. Botticella (2017)
10.1016/j.ijrobp.2010.10.049
Radiotherapy in pleural malignant mesothelioma: why not! In regard to Scorsetti et al. (Int J Radiat Oncol Biol Phys 2010;77:942-949); Krayenbuehl et al. (Int J Radiat Oncol Biol Phys 2010;78:628-634).
Elvio Grazioso Russi (2011)
10.1111/1759-7714.12008
Role of new radiation techniques in the treatment of pleural mesothelioma
M. Amichetti (2013)
10.1007/978-3-319-52619-5_36-1
Radiation Therapy in Mesothelioma
J. Willmann (2019)
10.1016/j.rpor.2019.09.002
Cardiotoxicity of mediastinal radiotherapy.
I. Ratosa (2019)
10.1016/j.prro.2020.05.004
Consensus Statement on Proton Therapy in Mesothelioma.
J. Zeng (2020)
10.1120/jacmp.v14i4.4130
Intensity‐modulated radiotherapy and volumetric‐modulated arc therapy for malignant pleural mesothelioma after extrapleural pleuropneumonectomy
J. Krayenbuehl (2013)
10.1002/cncr.26037
Proton‐based radiotherapy for unresectable or incompletely resected osteosarcoma
I. Ciernik (2011)
10.2217/LMT.15.15
Optimizing hemithoracic pleural intensity-modulated radiation therapy for malignant pleural mesothelioma
F. Shaikh (2015)
10.1007/s11912-011-0172-1
Medical Treatment of Mesothelioma: Anything New?
N. Takigawa (2011)
10.1097/JTO.0b013e3182199819
Intensity-Modulated Radiotherapy After Extrapleural Pneumonectomy in the Combined-Modality Treatment of Malignant Pleural Mesothelioma
A. Chi (2011)
10.1016/J.CANRAD.2013.06.045
Tomothérapie hélicoïdale dans le traitement du mésothéliome pleural malin : impact des faibles doses sur la toxicité pulmonaire et œsophagienne
J. Hélou (2012)
10.1118/1.3683640
Is there a single spot size and grid for intensity modulated proton therapy? Simulation of head and neck, prostate and mesothelioma cases.
L. Widesott (2012)
10.1186/1748-717X-9-32
Clinical outcome of postoperative highly conformal versus 3D conformal radiotherapy in patients with malignant pleural mesothelioma
J. Krayenbuehl (2014)
10.1111/php.13065
A Novel Prospective Study Assessing the Combination of Photodynamic Therapy and Proton Radiation Therapy: Safety and Outcomes When Treating Malignant Pleural Mesothelioma
S. Rice (2019)
10.1016/j.ijrobp.2017.04.025
Heart Dosimetry is Correlated With Risk of Radiation Pneumonitis After Lung-Sparing Hemithoracic Pleural Intensity Modulated Radiation Therapy for Malignant Pleural Mesothelioma.
E. Yorke (2017)
See more
Semantic Scholar Logo Some data provided by SemanticScholar